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Intrarenal hemodynamic abnormalities in diabetic nephropathy mea-
sured by duplex Doppler sonography. Intrarenal hemodynamics were
studied by duplex Doppler sonography in 112 inpatients with type II
diabetes mellitus (DM; 65 males, 47 females, 58 13 years old). The
resistive index (RI) and pulsatility index (P1) of the interlobar arteries
were calculated. The patients were divided into four groups: group I
consisted of patients with urinary albumin excretion (UAE) < 20 g/min(N = 42), group 11 with 20 UAE < 200 (N = 28), group III with UAE
200 (N = 25), and group IV with serum creatinine 1.5 mgldl (N 17).
Both RI and P1 values in groups 11, III, and IV were significantly higher
than those in the controls (age- and sex-matched healthy persons, N = 37;
P < 0.001), and those in group IV were significantly higher than those in
groups I, II, and III (P < 0.0001). Multiple regression analysis revealed
that RI values in DM patients were significantly affected by creatinine
clearance, age, and duration of diabetes (R2 = 0.554, P < 0.0001). When
intima-medial thickness (IMT) of the femoral and carotid arteries were
measured by B-mode ultrasonography, RI values were significantly corre-
lated with both the femoral and carotid arterial IMT. These results
demonstrate that intrarenal hemodynamic abnormalities are present in
type II DM patients with nephropathy, and that intrarenal hemodynamics
are affected by decreased glomerular function and also probably by
advanced arteriosclerosis.
Duplex Doppler sonography, which simultaneously measures
both real-time and pulsed Doppler sonography, has been used
clinically to examine intrarenal hemodynamic abnormalities such
as obstructive renal diseases and renal allograft rejection [1—4]. In
diseases limited to the glomeruli, such as glomerulonephritis, the
clinical usefulness of this method is limited since the resistive
index (RI), measured by pulsed Doppler sonography, is poorly
correlated with serum creatinine levels [51 In active tubulointer-
stitial diseases (acute tubular necrosis and tubulointerstitial ne-
phritis) or vasculitis/vasculopathy, increased RI values have been
reported [5]. The mechanisms leading to an increase in RI are not
known. So far, few reports describing the application of duplex
Doppler sonography in patients with diabetes mellitus (DM) have
been published [6, 7].
In this report, we examined intrarenal hemodynamics in pa-
tients with type II DM and found intrarenal hemodynamic
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abnormalities in patients with nephropathy. We analyzed the
factors associated with increased RI values. We further measured
the intima-medial thickness (IMT) of the femoral and carotid
arteries in these patients by high-resolution B-mode ultrasonog-
raphy and compared the RI values and IMT of the two arteries.
We found that increased RI values are significantly correlated
with decreased glomerular function and probably with advanced
arteriosclerotic lesions within the kidneys of these patients.
Methods
Subjecfs
We evaluated 112 Japanese patients with type II DM. The
diagnosis of DM was based on a previous history of diabetes or
criteria according to the World Health Organization [81. All
patients were admitted to Osaka City University Hospital for the
treatment of DM and an educational course on diabetes. As a
control group, 37 age- and sex-matched subjects were examined.
Each subject gave informed consent to participate in the study.
None of the control subjects had proteinuria, renal insufficiency,
diabetes, hypertension, cardiovascular disease, cerebrovascular
disease, or peripheral vascular disease. In each diabetic patient,
24-hour urine collections were performed during three consecu-
tive days in order to determine the level of urinary albumin
excretion (UAE) and creatinine clearance. In each patient, the
level of 24-hour urinary albumin excretion was the mean value
from three consecutive days. Creatinine clearance was calculated
from 24-hour urine samples and serum creatinine levels. Diabetic
patients were divided into four groups according to UAE and
serum creatinine levels as follows: group I consisted of patients
with UAE less than 20 g/min (N = 42); group II had a UAE
equal to or more than 20 jLg/min and less than 200 .Lglmin (N =
28); group III had a UAE equal to or more than 200 igImin (N =
25); and group IV had a serum creatinine equal to or more than
1.5 mg/dl (N = 17). All the group IV patients had UAE of more
than 200 .tg/min. To exclude patients with nondiabetic or obstruc-
tive kidney diseases, the patients with microscopic or macroscopic
hematuria, or an abnormal urinary sediment, a past history of
glomerulonephritis or nephro-ureterolithiasis, or dilated renal
pelvis on real-time ultrasonography, were excluded from this
study. The patients who had severely atrophied kidney(s), either
unilateral or bilateral, were also excluded from this study because
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Table 1. Clinical characteristics of the control and diabetic subjects
Control Group I Group II Group III Group IV
Number of patients male/female
Age years
37
(17/20)
58.5 12.5
42
(24/18)
55.7 14.0
28
(15/13)
61.7 12.1
25
(15/10)
55.7 11.6
17
(11/6)
64.7 7.5
Duration of diabetes years — 7.3 5.7 13.2 10.7 14.3 7.2 17.1 7.9
Body mass index kg/rn2
Fasting plasma glucose mg/dl
21.5 1.8
81 10
22.5 3.8
184 64'
22.7 3.3
194 81b
22.6 3.8
181 56b
22.6 3.8
133 46
Hb A % — 10.2 2.5 9.9 2.6 9.3 2.5 6.8 1.5
Total cholesterol mg/dl
Serum creatinine mg/dl
Blood urea nitrogen mg/dl
—
0.69 0.20
14.9 4.2
202 45
0.64 0.20
15.5 4.2
211 53
0.63 0.20
18.0 5.6
216 63
0.82 0.39
17.7 6.1
242 56
3.44 1.64k
43.8 13.2k
Creatinine clearance mI/mm — 97.6 37.9 91.2 32.2 72.7 29.9 14.4 9.3
Mean blood pressure mm Hg 82 13 91 13 97 13 103 17b 105 8
Data are expressed as the mean SD. HbAC is glycohemoglobin A1.
a P < 0.01 vs. controlbP < 0.001 vs. control
of poor imaging of blood flow with real time/color coded sonog-
raphy and difficulty in detecting a waveform. Twenty-five diabetic
patients were treated by diet alone (25 to 30 kcal per ideal body
weight), 60 patients with sulfonylureas, and 27 with insulin
therapy. As previously reported [9, 10], blood pressure was
measured three times with a standard mercury sphygmomanom-
eter and a cuff around the arm. Subjects rested in a supine position
for at least 10 minutes before blood pressure measurements, and an
average of the three measurements was documented. The clinical
and biochemical characteristics of the control and diabetic sub-
jects within each group are summarized in Table 1.
Biochemical analysis
Blood was drawn from patients in a supine position after an
overnight fast for the analysis of plasma levels of glucose, hemo-
globin A1 (Hb A1), blood urea nitrogen, serum creatinine, and
total cholesterol. Plasma levels of glucose were measured using
the glucose oxidase method. Hb A1 was measured by high-
performance liquid chromatography (HI-AUTO A1C; Sekisui
Chemical, Co. Ltd., Osaka, Japan). Blood urea nitrogen and
serum and urine creatinine were measured by an autoanalyzer.
Urinary albumin was measured irs 24-hour urine collections by
immunoturbidmetry (TIA MicroAlb Kit; Nittobo, Tokyo, Japan),
and the UAE rate was expressed in .tg/min.
Duplex Doppler sonography
Ultrasound examinations by a duplex Doppler apparatus were
performed with subjects in a supine position after they rested for
15 minutes, as previously reported by us and others [2, 5, 6].
Images were obtained with a duplex Doppler apparatus (Aloka
SSD 2000; Aloka, Tokyo, Japan) with a 5-MHz convex array
probe in both real-time/color-coded Doppler and pulsed Doppler
modes. The ultrasound probe was positioned gently on the flank
in an oblique projection, and the kidney was visualized as a
longitudinal image. To examine the interlobar arteries, we ob-
tained real-time/color-coded Doppler mode images, in which
intrarenal arterial and venous flows are shown in different colors.
Sample volumes were obtained to position the cursor of the
pulsed Doppler mode at the mid-portion of the interlobar arteries
which flow along the renal pyramid. The pulsed Doppler mode
was used to obtain quantitative measurements of velocity by
placing a cursor along the course of the interlobar arteries. The
sample volume was adjusted to a pulse length of 1.0 mm, and was
estimated using the angle correction menu of the apparatus. The
examination was completed in 15 minutes.
The peak systolic flow velocity (PSV), the end-diastolic flow
velocity (EDV), and the time-averaged flow velocity (TAV) were
automatically calculated by the ultrasound apparatus. Flow veloc-
ities were determined from signals that were stable for at least five
pulse beats, and measurements represented the average of five
complete waveforms. The resistance parameters, resistive index
(RI) and pulsatility index (P1), were determined as follows [1—3, 9,
11, 12]:
RI = (PSV - EDV)/PSV
PT = (PSV — EDV)ITAV
All measurements were performed by the same examiner (E.I.),
who was unaware of the subject characteristics. Three different
interlobar arteries from each kidney were randomly selected and
examined, and a mean value from the two kidneys was calculated.
When an RI or P1 value deviated greatly from the other two
values in a kidney, as sometime occurred in group IV patients,
more than four RI and P1 values from the kidney were obtained,
the outlying values were omitted, and a mean of the remaining
values was calculated. Since patients with unilateral atrophied
kidneys were excluded from the study as stated above, significant
differences in RI and P1 values between the right and left kidney
were not observed. Twenty-seven subjects (20 type II DM patients
and 7 controls) were examined on two different occasions, sepa-
rated by 2 to 10 days to estimate the intraobserver variability of
the RI and P1 values by the same examiner (El.), who was
unaware of values from the first examination. The coefficient of
variance for RI values was 3.8% and that for P1 was 6.8%.
Measurements of intima-medial thickness of the carotid and
femoral arteries
To measure intima-medial thickness (IMT), ultrasonographic
scanning of the carotid and femoral arteries was performed with
high resolution real-time ultrasonography using a 10-MHz in-line
Sectascanner (SSD 650 CL; Aloka Co.), as described previously
[10, 13—16]. Each subject was examined in a supine position. The
carotid and femoral arteries were investigated bilaterally. The
* *
**
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Fig. 1. Resistive index (RI) of the interlobar arteiy of the control subjects and
diabetic patients. Group I consisted of patients with urinaly albumin
excretion (UAE) less than 20 /.Lg!min (N = 42); group II had UAE 20
and < 200 p.glmin (N = 28), group III had UAE 200 Jsg/min (N = 25),
and group IV had a serum creatinine 1.5 mg'dl (N = 17). Data are
expressed as the mean SD. P < 0.0001 vs. controls; ** < 0.0001 vs.
controls, group I, group II, and group III.
0
2.50
2.00
1.50
1.00
0.50
carotid arteries were scanned at the levels of the bifurcation and
the common carotid artery. The femoral artery was examined
distal to the inguinal ligament at the site where the artery divided
into the superficial and profundus femoral arteries. These regions
were scanned bilaterally in longitudinal and transverse projec-
tions. The image was focused on the far wall of these arteries. The
site of the most advanced atherosclerotic lesion and the projection
that showed the greatest distance between the lumen-intimal
interface and the media-adventitial interface [intima-media thick-
ness (IMT)] was located in both the right and left carotid and
femoral arteries [10, 13—15, 17]. IMT was measured from the
digitized still images of the arteries during scanning. IMT was
defined as the distance between the leading edge of the lumen-
intimal interface to the leading edge of the media-adventitial
interface of the far wall. Measurement of the far wall was chosen,
since the luminal-intimal interfaces of the near wall were fre-
quently invisible during our examinations (approximately 20% to
30% of examined cases) [10, 13, 16]. Three still images from the
same section of the artery were measured, and a mean value was
calculated.
Statistical analysis
Statistical analysis was performed with the Stat View IV system
designed for the Macintosh Computer. All data are expressed as
means SD. One-way analysis of variance (ANOVA, Scheffe's
F-test) and chi-square test were performed for comparison of the
control group and four subject groups. Multiple regression anal-
ysis was performed to assess the combined influence of clinical
variables on the RI values, Correlation and linear regression
analyses was performed to examine the relationship between RI
values and creatinine clearance or age, and between the RI values
and IMT of femoral or carotid arteries.
Results
RI and P1 of intrarenal arteries in the control and diabetic subjects
RI values were 0.660 0.041 in the control subjects, similar to
previous reported value by us and others [1, 2, 4—7]. In the DM
patients, RI values were 0.698 0.058, 0.740 0.074, 0.742
0.066, and 0.852 0.05 1 in groups I, II, III, and IV, respectively.
RI values in the group I patients were higher than those in the
control subjects, although this difference was not statistically
significant (P = 0.0965). RI values in group II, III, and IV patients
were significantly higher than those in the control subjects (P <
0.0001). Patients in the group with diabetic nephropathy with
increased values of albuminuria and serum creatinine had in-
creased RI values. The RI values in group IV were significantly
higher than those in group I, II, and III patients (P < 0.0001),
although statistical significance was not reached among the RI
values in groups I, II, and III (P = 0.0770 between group I and II;
P = 0.0685 between group I and III; not significant between group
II and III; Fig. 1).
P1 values were 1.107 0.162 in the control subjects. In DM
patients, P1 values were 1.288 0.270, 1.504 0.428, 1.489
0.368, and 2.111 0.444 in groups 1, II, III, and IV, respectively.
P1 values in group 1 patients were not significantly higher than
those in control subjects (P = 0.1665). P1 values in the group II,
III, and IV patients were significantly higher than those in the
control subjects (P < 0.0002, P < 0.0006, and P < 0.0001,
respectively). Among the DM patients, P1 values in group IV were
significantly higher than those in groups I, II, and III (P < 0.0001,
respectively), while there was no statistical significance among the
P1 values in group I, II, or III patients (P > 0.1; Fig. 2).
Since there were relatively larger standard deviations and
coefficients of variance in P1 values than in RI values, RI values
were used in the following analysis to assess factors affecting
intrarenal diabetic hemodynamics.
Analysis of clinical variables affecting RI values in diabetic patients
To examine the combined influence of clinical variables on RI
values, a multiple regression analysis was performed with a model
using creatinine clearance, age, duration of diabetes, fasting
plasma glucose, Hb A1, total cholesterol, sex (male, 0; female, 1)
and mean blood pressure as independent variables. Among these
variables, RI values in DM patients were significantly affected by
0
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Group I Group II Group III Group IV
(N=42) (N=28) (N=25) (N=17)
Fig. 2. Pulsatility index (P1) of the interlobar artety of the control subjects
and diabetic patients. Group divisions are the same as in Figure 1. Data are
expressed as the mean so. *P < 0.001 vs. controls; ** < 0.0001 vs.
controls, group I, group II, and group III.
*
*
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Table 2. Clinical factors affecting the resistive index of the renal
interlobar arteries
Variables
/3 P < R2Dependent Independent
Resistive Creatinine clearance —0.364 0.0001
index Age
Duration of diabetes
Fasting plasma glucose
HbAIC
Total cholesterol
Sex
Mean blood pressure
0.277
0.22 1
—0.115
—0.119
0.085
—0.028
0.009
0.0005
0.0025
0.1951
0.2046
0.2410
0.6966
0.9071 0.554
(P < 0.0001)
Abbreviations are: /3, standard regression; R2, multiple coefficient of
determination.
Creatinine clearance, mi/mm
Fig. 3. Correlation between the RI values and creatinine clearance in
diabetic patients. A significant, negative correlation existed between the
two measurements. r =
—0.630; P < 0.001.
Age, years
Fig. 4. Correlation between the RI values and age of diabetic patients. A
significant, positive correlation existed between the two measurements.
r = 0.523; P < 0.001.
MT of the femoral artery, mm
creatinine clearance (/3 =
—0.364), age (3 = 0.277), and duration
of diabetes (f.3 = 0.221; R2 = 0.554, P < 0.0001), but not by the
other variables (Table 2).
The relationship between the RI values and creatinine clear-
ance in diabetic patients showed a negative correlation coefficient
of r = —0.630 (P <0.001; Fig. 3), The relationship between the RI
values and age of diabetic patients showed a positive correlation
coefficient of r = 0.523 (P < 0.001; Fig. 4). There was no
relationship between creatinine clearance and age in diabetic
patients (data not shown).
Relationship between RI values and IMT of femoral or carotid
arteries
To examine the relationship between RI values and arterioscle-
rosis, RI values were compared with the femoral and carotid IMT.
Significant, positive correlations between RI values and IMT of
the femoral arteries, and between the RI values and IMT of the
carotid arteries existed (r = 0.391, P < 0.001, and r = 0.264, P <
0.004, respectively; Figs. 5 and 6).
Fig. 5. Correlation between the RI values and intima-medial thickness
(JMT) of the femoral artely of diabetic patients. A significant, positive
correlation existed between the two measurements. r = 0.391; P < 0.001.
Discussion
The use of duplex Doppler sonography to examine various
renal disorders such as renal allograft rejection [1, 31, obstructive
kidney disease [2], renovascular hypertension [18], and parenchy-
mal renal disease [51 have been reported. We used sonography to
examine intrarenal hemodynamic changes noninvasively in pa-
tients with type II DM. We demonstrated the presence of
intrarenal hemodynamic abnormalities in type II DM patients
with nephropathy, defined by the presence of increased albumin-
uria and renal insufficiency. From the resistance parameters used
in the present study, RI values had a relatively smaller coefficient
of variance and standard deviation than P1 values, as seen in our
previous study [6, 9]. A smaller standard deviation for RI values
compared with P1 values was also seen in a duplex Doppler
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Fig. 6. Correlation between the RI values and intima-medial thickness
(IMT) of the carotid artely of diabetic patients. A significant, positive
correlation existed between the two measurements. r = 0.264; P < 0.004.
ultrasonography study of renal allografts [4]. Even using different
resistance parameters, we found a significant increase in both RI
and P1 values in type II diabetic patients with nephropathy
(groups II, III, and IV), compared to control subjects. These
results partially agree with the results of a French study [7], in
which RI values of DM patients both with and without renal
insufficiency were shown to be significantly elevated. In that study,
DM patients without renal insufficiency included both those with
and without proteinuria. In our study, DM patients without renal
insufficiency were further divided according to the levels of
albuminuria. We found a significant increase in RI values in
patients with UAE equal to or more than 20 ag/min (groups II
and III), compared to age- and sex-matched control subjects.
Further, a trend towards higher RI values was observed between
patients in group II and group III and patients with a UAE less
than 20 igImin (group I).
In the present study, factors affecting the RI values were
examined. In multiple regression analysis, the most significant
factor affecting the RI values in DM patients was found to be
creatinine clearance. As creatinine clearance decreased, RI values
increased. This result is consistent with that of Platt et al [5], who
demonstrated that in various renal diseases, RI values of patients
with normal creatinine levels were significantly lower than those
with elevated creatinine levels, despite a weak correlation be-
tween serum creatinine levels and RI values (r 0.34). However,
compared to their results, we found that the correlation coefficient
between creatinine clearance and RI values was relatively high
(r =
—0.630). These results may be due to differences in the
method used in assess renal function, as serum creatinine levels
were measured in their study and creatinine clearance in our
study. In addition, they may be attributable to differences in the
disease populations, since their study included patients with a
variety of diseases, such as glomerulonephritis, tubulointerstitial
diseases and vasculitis/vasculopathy (the latter two had high RI
values, seemingly independent of serum creatinine levels), and
our study included type II DM patients only. Our results agree
with those of Sauvain et al, in which DM patients with renal
insufficiency showed higher levels of RI values than those without
renal insufficiency [7]. Our present study clearly demonstrates that
in patients with type II DM, creatinine clearance, which is closely
related to glomerular function, is strongly and significantly corre-
lated with RI values. The mechanisms for increased RI values in
patients with decreased glomerular function is unknown. Sclerotic
glomeruli in advanced diabetic nephropathy may cause increased
blood flow resistance measurable at an upstream interlobar artery.
In advanced diabetic nephropathy, glomeruli become sclerotic,
tubuli become atrophic, and interstitial fibrosis is increased [19,
20]. Increased interstitial fibrosis may cause elevated RI values in
advanced diabetic nephropathy, as elevated RI values have been
reported in tubulointerstitial diseases [5].
By multiple regression analysis, the other significant factors
affecting the RI values in DM patients were demonstrated to be
age and duration of diabetes (/3 = 0.277 and /3 = 0.221, respec-
tively). As age increased, RI values increased. Age was not
significantly correlated with creatinine clearance, which had the
greatest influence on RI values in the present study. There have
been no previous reports demonstrating a relationship between
increased RI values and age. Platt et al have reported that among
patients with nonobstructive (medical) diseases, those with vascu-
litis/vasculopathy had extremely high RI values (mean RI =
0.82 0.05) [5]. Frauchiger et a! have recently reported that renal
allografts with biopsy-proven vascular rejection showed greatly
increased RI values (mean RI = 0.80 0.18), although other
types of rejection showed relatively normal RI values [1]. These
results strongly suggest that intrarenal vasculopathy causes high
RI values. In the present study, factors associated with intrarenal
vasculopathy could be considered in diabetic patients. It is well
known that advanced arteriosclerosis occurs with increasing age
[13—15, 21—25]. In addition, diabetes is a strong risk factor for
arteriosclerosis [15, 26—30], and a long duration of diabetes is a
significant risk factor for advanced arteriosclerosis [14, 15, 31, 32].
Taken together, one can speculate that significant contributions of
patient age and duration of diabetes to increased RI values may
be due to advanced arteriosclerosis. Furthermore, renal diseases,
defined as microalbuminuria and macroalbuminuria in DM pa-
tients, is known to be a risk factor for widespread vascular damage
[28, 32]. Microalbuminuria has also been demonstrated to be a
predictor of vascular disease in nondiabetic subjects [33—35].
These suggest that the significant increase in RI values in patients
with microalbuminuria and macroalbuminuria (groups II and III)
may have been caused by increased vascular damage (arterioscle-
rosis).
To further examine the possible contribution of advanced
arteriosclerosis to increased RI values of the interlobar artery, we
studied the relationship between RI values and the IMT of the
femoral and carotid artery. We found significant, positive corre-
lations between RI values and the femoral artery IMT, and
between RI values and the carotid artery IMT. Although the sizes
of the femoral and carotid artery are different from that of the
interlobar artery of the kidney, the extent and severity of arterio-
sclerosis of the medium-sized arteries (such as the carotid and
femoral arteries) and small-sized arteries (such as the coronary
and renal arteries) have been reported to be correlated in autopsy
studies [36, 37]. According to an extensive autopsy study per-
formed in a well-defined population in a limited region of
Malmae, Sweden (69.8% of all deaths were autopsied during 1961
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to 1962), significant correlations were found in the degree of
arteriosclerosis among the carotid, femoral, and renal arteries
(including the orifice of segmental arteries; P < 0.01), and their
correlation coefficients ranged from 0.28 to 0.38 [361. A close
association of arteriosclerosis among arteries of different size has
been demonstrated [24, 25, 29—31, 36—391, showing the systemic
nature of arteriosclerosis and its relationship to hypertension, age,
and diabetes mellitus. However, arteriosclerosis varies to a certain
extent among arteries of different size, as shown in the Malmae
study [361. Thus, the significant correlations between IMT of the
two arteries and RI values of the interlobar artery are indirect
evidence for the possible contribution of advanced intrarenal
arteriosclerosis to increased RI values. Arteriosclerosis in the
kidney frequently causes tubular atrophy and interstitial fibrosis.
Advanced tubulointerstitial lesions may contribute to increased
RI values in these patients, since tubulointerstitial lesions have
been reported to result in elevated RI values [51. We have
previously reported that uremia accelerated arteriosclerosis of the
carotid and femoral arteries [10]. Contribution of decreased
creatinine clearance to the increased RI values may, in part, be via
accelerated arteriosclerosis induced by uremia.
Histopathologically, nephropathy in type II diabetes is consid-
ered to be different from that in type I diabetes and to be more
heterogeneous [40, 41]. Gambara et al evaluated pathologic
changes in 52 type II diabetics with overt clinical nephropathy,
and found two types of pathologic changes (Class I and Class II)
in addition to glomerular lesions unrelated to diabetes (Class III)
[40]. Class I (37%) changes are similar to those seen in the
nephropathy of type I diabetics, with glornerular hypertrophy and
typical diabetic glomerulosclerosis. Class 11(30%) changes are
nonspecific, frequently with global glomerulosclerosis, interstitial
fibrosis, tubular atrophy, and severe arteriosclerosis. The latter
type (Class II) of overt clinical nephropathy in type II diabetics
was considered to consist of chronic vascular (arteriosclerotic
type) and tubulointerstitial lesions. Actually, in most patients with
diabetic nephropathy, both types are thought to occur together
[42—44]. In the present study, even in the patients with similar
values for creatinine clearance or urinary albumin excretion,
differences in resistance parameters were present. Considering
that arteriosclerotic lesions or interstitial lesions that are fre-
quently associated with diabetic nephropathy may be associated
with increased RI values, measurement of resistance parameters
could provide a useful information about such lesions [40, 42—44].
Arteriosclerotic lesions and/or tubulointerstitial lesions cannot be
identified by blood analysis or assessment of albuminuria 140].
They can only be identified by histologic examination of renal
tissue specimens obtained invasively [40]. As Gambara et al could
find no difference between the clinical outcomes of patients with
Class I or II lesions because of a relatively short duration of
observation [40], further prospective studies are needed to estab-
lish if patients with higher RI values but a similar degree of
albuminuria and creatinine clearance progress more rapidly to
end-stage renal failure. Recently, angiotensin converting enzyme
(ACE) inhibitors have been shown to delay the progression of
diabetic nephropathy, slowing the decrease in glomerular filtra-
tion rate by decreasing the intraglomerular capillary pressure
[45—47]. Patients with extremely high RI values compared to
those with lower ones who have a similar creatinine clearance and
degree of albuminuria may be more susceptible to ACE inhibitor-
induced renal ischemia, as are patients with atherosclerosis or
renal artery stenosis [48, 49].
Among resistance parameters measured by duplex Doppler
sonography, RI values have been most frequently used in clinical
practice. Our study also demonstrated that RI values are more
useful than P1 values because of smaller coefficients of variance
and standard deviations. In our previous study, the intra-operator
coefficients of variance were small, less than 5% [6]. However,
normal ranges for RI values varied among reports by other
authors who used different sonography machines and examined
subjects of different ages with different diseases. It is reported to
vary from 0.58 to 0.68 in normal (control) kidneys or normally
functioning allografts [1, 2, 4—7, 18, 501. In our study, RI values in
control subjects (0.660 0.041) who were relatively older (58.5
12.5 years) were a little higher than the previous report. Since a
weak positive correlation existed between age and RI values in the
control group (although not statistically significant) and the mean
age of seven patients with RI values exceeding + I SD was 68 years,
the normal range of RI values may be affected by age. It also has
been shown that heart rate can affect RI values [50], although it is
almost negligible in practice [1]. Although it is difficult to set a
normal range for RI because of limitations in the gold standard
proof of normal renal status, particularly considering the possible
influence of age-related arteriosclerosis on RI values, Platt sug-
gested 0.70 as a reasonable upper limit for normal RI values after
examining patients with various renal diseases [5]. In our study,
mean RI values of patients with microalbuminuria, overt protein-
uria, and renal insufficiency were all above the limit suggested by
Platt. Thus, we consider that an RI values greater than 0.70
suggests advanced glomerular lesions and/or arteriosclerotic le-
sions in type II diabetics who average 60 years old, even though
the normal RI values may vary among operators or sonography
machines.
In conclusion, the present study demonstrates that duplex
Doppler sonography is useful in the noninvasive assessment of
intrarenal hemodynamic abnormalities present in diabetic ne-
phropathy. In addition, RI values may be a more useful marker
for the assessment of intrarenal hemodynamics than P1 values. RI
values were significantly affected by decreased glomerular func-
tion, advanced age, and long duration of diabetes. The latter two
factors may affect RI values through advanced arteriosclerosis,
and the association of arteriosclerosis was also suggested by
significant correlations between RI values and IMT of the femoral
and carotid artery. Although further studies are needed, RI values
may be a useful tool to evaluate the arteriosclerotic lesions of
intrarenal small arteries in patients without renal insufficiency,
since there are few useful methods to assess small artery lesions
other than biopsy or post-mortem examination.
Reprint requests to Dr. Eiji Ishimura, Second Department of Internal
Medicine, Osaka City University Medical School, 1-5-7, Asahi-machi, Aheno-
ku, Osaka 545, Japan.
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